FDA Inspection 1103065 — Gabor Rubovszky
The FDA completed an inspection of Gabor Rubovszky on Mar 8, 2019 in Budapest Xii. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 8, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Budapest Xii (Hungary)
Additional Details
Clinical Investigator (CI)